Trial intelligence / Profile preview

Effects of D-camphor and hawthorn berries liquid extract on low blood pressure and cognitive/mental functions

2014-005327-27Phase 3

Sponsor
Robugen
Start
May 2015
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of Camphor and camphor + hawthorn berry extract in hypotension, sponsored by Robugen. Primary endpoint: Change of low blood pressure.

02

Drugs

Camphorcamphor + hawthorn berry extract
03

Conditions

hypotension

Beyond the preview

Go deeper on 2014-005327-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005327-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call